San Diego biotech to work with J&J unit on diabetes drugs

12/23/2004 | San Diego Union-Tribune

Arena Pharmaceuticals said it and Johnson & Johnson's Ortho-McNeil Pharmaceutical division will collaborate on type 2 diabetes drugs, based on Arena's compounds still in the early lab testing phase. The $17.5 million Ortho-McNeil is to pay up front is considered a high price for an experimental compound, and that payment is to be followed by another $4.8 million in research funds over a two-year period.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA